The Clinton Health Access Initiative (CHAI) has teamed up with UNITAID and the UK’s Department of International Development (DFID) to negotiate new price reductions on key antiretroviral (ARV) drug regimens. Today’s announcement means HIV/AIDS treatment will be more widely available as the newly reduced price ceilings will be available to most of the 70 countries […]
Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, is arguably the U.S. government’s best-known scientist. John Donnelly interviewed Dr. Fauci for Science Speaks’ series on the 30th anniversary since the discovery of a virus that would turn out to be HIV, and he talked about everything from how he first learned of the disease, to his surprise in President George W. Bush’s commitment, to the unmet needs today to fight the pandemic. Read more…
HIV
Once outbreak was recognized, program put in place reduced number of ongoing transmissions, modeling shows In 2015, when 181 of rural Scott County, Indiana’s 24,000 residents […]
Tuberculosis
SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Ruth Ashton of MEASURE Evaluation CHAPEL HILL, NC―A new study released today in the Lancet’s eClinicalMedicine shows that routine […]